FGF19 and fatty liver disease: FGF19 requires KLB expression in the liver to regulate Cyp7a1 expression in mice (91), while the positive effect of FGF19 and FGF21 on hepatic steatosis was unaffected by adipose and liver specific KLB deletion (91).